FTC Declares Victory in Generic Drug Case

FTC Declares Victory in Generic Drug Case Play

June 17 (Bloomberg) -- Drugmakers can be sued for paying rivals to delay low-cost versions of popular medicines, the U.S. Supreme Court said in a decision that rewrites the rules governing the release of generic drugs. Olivia Sterns reports on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

blog comments powered by Disqus